A technology developed by the Brazilian company brain4care has been shown to be able to measure absolute values of intracranial pressure (ICP) more accurately than existing non-invasive methods.
Monitoring of intracranial pressure (ICP) has profound implications to the status of a patient's cerebral autoregulation, and the direction of necessary neurotherapeutics. Understanding the mixed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback